Stock listing

NASDAQ:BBNX Beta Bionics, Inc. Stock

Home listing (NASDAQ) of Beta Bionics, Inc.

Follow Beta Bionics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BBNX

$16.35 USD -0.96 (-5.5%)

Close on Oct 16, 2026

Beta Bionics, Inc. logo
Ticker
NASDAQ:BBNX
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Upcoming

  • Beta Bionics (NASDAQ:BBNX) Q3 2026 Earnings Call

    Tue, Oct 27, 2026 · 4:30 PM ET

    Register

Replays

  • Beta Bionics (NASDAQ:BBNX) Q2 2026 Earnings Call

    Wed, Jul 29, 2026 · 4:30 PM ET

    Watch Transcript

  • Beta Bionics (NASDAQ:BBNX) Q1 2026 Earnings Call

    Tue, Apr 21, 2026 · 4:30 PM ET

    Watch Transcript

  • Beta Bionics (NASDAQ:BBNX) Q4 2025 Earnings Call

    Tue, Feb 17, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNX

Oct 5, 2026

Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026

Sep 29, 2026

Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365

Sep 22, 2026

Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock

Sep 17, 2026

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Sep 15, 2026

Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock

Sep 15, 2026

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

Sep 14, 2026

Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

Jul 29, 2026

Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026

Jul 1, 2026

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

Jun 2, 2026

All Beta Bionics, Inc. news

Financings

  • Public offering of common stock and pre-funded warrants

    Sep 17, 2026

    Closed: US$172.5M raised · US$17.25 a share · J.P. Morgan +3

    Dealers: J.P. Morgan (co-lead), Piper Sandler (co-lead), Wells Fargo Securities (co-lead), Leerink Partners (co-lead)

    Use of proceeds: General corporate purposes, including commercialization of Mint, manufacturing expansion, R&D and clinical development, and working capital

    Announced Sep 15, 2026 · Closed Sep 17, 2026

Read by 6ix AI from the company's releases

Decks

Beta Bionics, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
21 in the last 12 months · 35 in all · newest Oct 5, 2026 · oldest 2025
Calls
6 calls with a replay · 6 with a transcript · latest Jul 29, 2026
Decks
9 decks · latest Sep 15, 2026

Where Beta Bionics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BBNX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BBNXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Beta Bionics, Inc.